Search Prime Grants

W81XWH2210301

Project Grant

Overview

Grant Description
Titre: Trial of indication-based transfusion of red blood cells in ECMO.
Awardee
Children's Hospital Corporation
Grant Program (CFDA)
12.420 - Military Medical Research and Development
Awarding / Funding Agency
Defense Health Agency (DHA) [DoD]
Place of Performance
Boston, Massachusetts 021155724 United States
Geographic Scope
Single Zip Code
Related Opportunity
None
Analysis Notes
Amendment Since initial award the total obligations have decreased 100% from $8,927,797 to $0.
Children's Hospital Corporation was awarded ECMO Trial: Indication-Based RBC Transfusion Project Grant W81XWH2210301 from Defense Health Agency in July 2022 with work to be completed primarily in Boston Massachusetts United States. The grant has a duration of 4 years and was awarded through assistance program 12.420 Military Medical Research and Development.

Status
(Ongoing)

Last Modified 12/14/23

Period of Performance
7/1/22
Start Date
6/30/26
End Date
79.0% Complete

Funding Split
$0.0
Federal Obligation
$0.0
Non-Federal Obligation
$0.0
Total Obligated
100% Federal Funding
0% Non-Federal Funding

Transaction History

Modifications to W81XWH2210301

Additional Detail

Award ID FAIN
W81XWH2210301
SAI Number
None
Award ID URI
None
Awardee Classifications
Nonprofit With 501(c)(3) IRS Status (Other Than An Institution Of Higher Education)
Other
Awarding Office
HT9425 ARMY MED RES ACQ ACTIVITY
Funding Office
HT0989 CONG DIR MED RES PRGM / CDMRP - MM
Awardee UEI
Z1L9F1MM1RY3
Awardee CAGE
2H173
Performance District
MA-07
Senators
Edward Markey
Elizabeth Warren
Modified: 12/14/23